Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 6, 2010, Pages 712-721

  Kasraie, S ^a   Niebuhr, M ^a   Werfel, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Atopic dermatitis; Human; IL 31 IL 31R; Macrophages; PBMC; SEB; Staphylococcus enterotoxin B; toxin

Indexed keywords

CD86 ANTIGEN; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 31; INTERLEUKIN 31 RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; EXOTOXIN; IL31 PROTEIN, HUMAN; IL31RA PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR;

ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; ECZEMA; GENETICS; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SECRETION (PROCESS); STAPHYLOCOCCUS;

CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ECZEMA; EXOTOXINS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; MACROPHAGES; MONOCYTES; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; STAPHYLOCOCCUS;

EID: 77951885440     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02255.x     Document Type: Article

References (36)

1. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004 57 : 752 760. (Pubitemid 39023308)
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003 361 : 151 160. (Pubitemid 36092023)
3. Greaves MW, Khalifa N. Itch: more than skin deep. Int Arch Allergy Immunol 2004 135 : 166 172. (Pubitemid 39377726)
4. Wittmann M, Werfel T. Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseases. Curr Opin Allergy Clin Immunol 2006 6 : 329 334. (Pubitemid 44368238)
5. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006 117 : 411 417. (Pubitemid 43192023)
6. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006 117 : 418 425. (Pubitemid 43190155)
7. Schulz F, Marenholz I, Folster-Holst R, Chen C, Sternjak A, Baumgrass R et al. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol 2007 120 : 1097 1102. (Pubitemid 350029903)
8. Perrigoue JG, Li J, Zaph C, Goldschmidt M, Scott P, de Sauvage FJ et al. IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J Exp Med 2007 204 : 481 487. (Pubitemid 46457072)
9. Lei Z, Liu G, Huang Q, Lv M, Zu R, Zhang GM et al. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 2008 63 : 327 332. (Pubitemid 351224674)
10. Raap U, Wichmann K, Bruder M, Stander S, Wedi B, Kapp A et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 2008 122 : 421 423.
11. Chattopadhyay S, Tracy E, Liang P, Robledo O, Rose-John S, Baumann H. Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J Biol Chem 2007 282 : 3014 3026. (Pubitemid 47084348)
12. Boulay JL, O'Shea JJ, Paul WE. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 2003 19 : 159 163.
13. Dambacher J, Beigel F, Seiderer J, Haller D, Goke B, Auernhammer CJ et al. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease. Gut 2007 56 : 1257 1265. (Pubitemid 47300428)
14. Diveu C, Lak-Hal AH, Froger J, Ravon E, Grimaud L, Barbier F et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur Cytokine Netw 2004 15 : 291 302. (Pubitemid 40127653)
15. Kiekens RC, Thepen T, Oosting AJ, Bihari IC, Van De Winkel JG, Bruijnzeel-Koomen CA et al. Heterogeneity within tissue-specific macrophage and dendritic cell populations during cutaneous inflammation in atopic dermatitis. Br J Dermatol 2001 145 : 957 965. (Pubitemid 34204471)
16. Breuer K, Wittmann M, Kempe K, Kapp A, Mai U, Dittrich-Breiholz O et al. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy 2005 35 : 1088 1095. (Pubitemid 41603144)
17. Wichmann K, Uter W, Weiss J, Breuer K, Heratizadeh A, Mai U et al. Isolation of α-toxin producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 2009 161 : 300 305.
18. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980 92 (Suppl. 44 47.
19. Novak N, Kraft S, Haberstok J, Geiger E, Allam P, Bieber T. A reducing microenvironment leads to the generation of FcepsilonRIhigh inflammatory dendritic epidermal cells (IDEC). J Invest Dermatol 2002 119 : 842 849. (Pubitemid 35340909)
20. Neis MM, Peters B, Dreuw A, Wenzel J, Bieber T, Mauch C et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006 118 : 930 937. (Pubitemid 44498762)
21. Jawa RS, Chattopadhyay S, Tracy E, Wang Y, Huntoon K, Dayton MT et al. Regulated expression of the IL-31 receptor in bronchial and alveolar epithelial cells, pulmonary fibroblasts, and pulmonary macrophages. J Interferon Cytokine Res 2008 28 : 207 219. (Pubitemid 351591445)
22. Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol 2004 4 : 373 378. (Pubitemid 39274078)
23. Laouini D, Kawamoto S, Yalcindag A, Bryce P, Mizoguchi E, Oettgen H et al. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol 2003 112 : 981 987. (Pubitemid 37412069)
24. Guzik TJ, Bzowska M, Kasprowicz A, Czerniawska-Mysik G, Wojcik K, Szmyd D et al. Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 2005 35 : 448 455. (Pubitemid 40577236)
25. Heise R, Neis MM, Marquardt Y, Joussen S, Heinrich PC, Merk HF et al. IL-31 receptor alpha expression in epidermal keratinocytes is modulated by cell differentiation and interferon gamma. J Invest Dermatol 2009 129 : 240 243.
26. Ip WK, Wong CK, Li ML, Li PW, Cheung PF, Lam CW. Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response. Immunology 2007 122 : 532 541.
27. Bunikowski R, Gerhold K, Brautigam M, Hamelmann E, Renz H, Wahn U. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int Arch Allergy Immunol 2001 125 : 344 348. (Pubitemid 34704647)
28. Junghans V, Gutgesell C, Jung T, Neumann C. Epidermal cytokines IL-1beta, TNF-alpha, and IL-12 in patients with atopic dermatitis: response to application of house dust mite antigens. J Invest Dermatol 1998 111 : 1184 1188. (Pubitemid 29115195)
29. Hasannejad H, Takahashi R, Kimishima M, Hayakawa K, Shiohara T. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 2007 120 : 69 75. (Pubitemid 46990500)
30. Kohno K, Okamoto I, Sano O, Arai N, Iwaki K, Ikeda M et al. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci Biotechnol Biochem 2004 68 : 138 145. (Pubitemid 39251576)
31. Yagi Y, Andoh A, Nishida A, Shioya M, Nishimura T, Hashimoto T et al. Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts. Int J Mol Med 2007 19 : 941 946. (Pubitemid 47456762)
32. El-Mezzein RE, Matsumoto T, Nomiyama H, Miike T. Increased secretion of IL-18 in vitro by peripheral blood mononuclear cells of patients with bronchial asthma and atopic dermatitis. Clin Exp Immunol 2001 126 : 193 198. (Pubitemid 32995131)
33. Wittmann M, Purwar R, Hartmann C, Gutzmer R, Werfel T. Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol 2005 124 : 1225 1233. (Pubitemid 40847410)
34. Odobasic D, Leech MT, Xue JR, Holdsworth SR. Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis. Immunology 2008 124 : 503 513. (Pubitemid 351962546)
35. Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and airway responsiveness. J Exp Med 1997 185 : 1671 1679. (Pubitemid 27203263)
36. Slavik JM, Hutchcroft JE, Bierer BE. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J Biol Chem 1999 274 : 3116 3124.